DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.690
-0.007 (-0.99%)
At close: Feb 21, 2025, 4:00 PM
0.693
+0.003 (0.49%)
After-hours: Feb 21, 2025, 5:17 PM EST
DarioHealth Revenue
DarioHealth had revenue of $7.42M in the quarter ending September 30, 2024, with 111.00% growth. This brings the company's revenue in the last twelve months to $23.05M, down -2.09% year-over-year. In the year 2023, DarioHealth had annual revenue of $20.35M, down -26.41%.
Revenue (ttm)
$23.05M
Revenue Growth
-2.09%
P/S Ratio
1.09
Revenue / Employee
$78,408
Employees
294
Market Cap
26.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
| Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
| Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
| Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
| Dec 31, 2019 | 7.56M | 165.00K | 2.23% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
DRIO News
- 16 days ago - DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base - PRNewsWire
- 23 days ago - PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation - Business Wire
- 4 weeks ago - DarioHealth Announces $25.6M Private Placement Positioning the Company to Execute on Strategy Aiming to Reach Operational Cash Flow Positive Run Rate by the End of 2025 - PRNewsWire
- 5 weeks ago - DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market - Business Wire
- 5 weeks ago - DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets - PRNewsWire
- 3 months ago - Dario Signs Four New Employer Contracts Across Full Product Suite - PRNewsWire
- 3 months ago - DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - DarioHealth Reports Third Quarter 2024 Financial and Operating Results - PRNewsWire